S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
MarketBeat All Access New Year's Sale - Just $1.00 (Ad)

Boston Scientific (BSX) Stock Forecast & Price Target

$57.81
+1.53 (+2.72%)
(As of 12/29/2023 ET)

Boston Scientific Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Buy
Based on 18 Analyst Ratings

Analysts' Consensus Price Target

$61.18
5.83% Upside
High Forecast$66.00
Average Forecast$61.18
Low Forecast$55.00
TypeCurrent Forecast
12/31/22 to 12/31/23
1 Month Ago
12/1/22 to 12/1/23
3 Months Ago
10/2/22 to 10/2/23
1 Year Ago
12/31/21 to 12/31/22
Consensus Rating
Buy
Buy
Buy
Moderate Buy
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
16 Buy rating(s)
14 Buy rating(s)
15 Buy rating(s)
11 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$61.18$60.55$60.10$49.77
Predicted Upside5.83% Upside14.66% Upside15.11% Upside18.45% Upside
Get Boston Scientific Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.


BSX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BSX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Boston Scientific Stock vs. The Competition

TypeBoston ScientificMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.67
2.49
Consensus RatingBuyModerate BuyHold
Predicted Upside5.83% Upside2,167.34% Upside6.98% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/29/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$62.00+10.16%
12/29/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$64.00+13.72%
12/22/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$59.00 ➝ $66.00+18.22%
12/12/2023TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$58.00 ➝ $65.00+17.62%
12/4/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$58.00 ➝ $61.00+8.64%
11/27/2023Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$60.00 ➝ $64.00+15.17%
10/27/2023Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$65.00 ➝ $60.00+20.53%
9/22/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$59.00 ➝ $60.00+11.15%
9/21/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$63.00+16.30%
9/21/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$58.00 ➝ $61.00+12.75%
9/21/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$63.00 ➝ $66.00+22.00%
9/21/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$58.00 ➝ $60.00+10.91%
9/21/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$60.00 ➝ $63.00+16.45%
9/21/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$56.00 ➝ $60.00+10.91%
9/19/2023Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$60.00+13.77%
7/28/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$60.00 ➝ $61.00+17.92%
7/28/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$58.00 ➝ $59.00+12.06%
7/6/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$58.00 ➝ $62.00+16.43%
6/30/202322nd Century Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingInitiates
6/30/2023CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$64.00+20.10%
4/27/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$45.00 ➝ $55.00+7.63%
2/17/2023Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$50.00 ➝ $55.00+18.53%
2/2/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$48.00 ➝ $55.00+15.69%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 08:35 PM ET.












BSX Price Target - Frequently Asked Questions

What is Boston Scientific's consensus rating and price target?

According to the issued ratings of 18 analysts in the last year, the consensus rating for Boston Scientific stock is Buy based on the current 1 hold rating, 16 buy ratings and 1 strong buy rating for BSX. The average twelve-month price prediction for Boston Scientific is $61.18 with a high price target of $66.00 and a low price target of $55.00. Learn more on BSX's analyst rating history.

Do Wall Street analysts like Boston Scientific more than its competitors?

Analysts like Boston Scientific more than other Medical companies. The consensus rating for Boston Scientific is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how BSX compares to other companies.

Does Boston Scientific's stock price have much upside?

According to analysts, Boston Scientific's stock has a predicted upside of 14.27% based on their 12-month stock forecasts.

What analysts cover Boston Scientific?

Stock Ratings Reports and Tools

This page (NYSE:BSX) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -